Moderna, Inc. (MRNA)

170.25
3.80 2.20
NASDAQ
Prev Close 174.07
Open 174.99
Day Low/High 168.28 / 177.47
52 Wk Low/High 117.34 / 497.49
Volume 9.50M
Exchange NASDAQ
Shares Outstanding 405.45B
Market Cap 75.66B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Futures Pop, Gilead's Covid-19 Treatment, Trading My 'Virus Group'

Futures Pop, Gilead's Covid-19 Treatment, Trading My 'Virus Group'

The rise in equity futures pricing was born of optimism from the president's task force draft guideline on reopening parts of the U.S. economy and Gilead Sciences' somewhat positive results on its remdisivir anti-viral treatment.

My New Multi-Group Portfolio Strategy for Trading the Pandemic

My New Multi-Group Portfolio Strategy for Trading the Pandemic

How has my book evolved since the Fed and Treasury rode into town? Here's how.

The Smartest Trader in the World

The Smartest Trader is still long all of his gold futures. However, he expressed concern that the precious metal is "getting a bit tired." He has no futures position. He thinks, save 8-10 stocks, the market is quite vulnerable to the downside. He ow...

The Virus Remains in Control, Unrealistic V-Shaped Recovery, Trading 2 Stocks

The Virus Remains in Control, Unrealistic V-Shaped Recovery, Trading 2 Stocks

I do think the key to reopening this economy is one of greatly expanded testing for Covid-19, once a reliable treatment has made it past clinical testing, and into mass production.

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

Consider these stock model ideas: virus groups, work remotely, and fiscal.

Congress Drags Its Feet as Markets Fall, 30% Unemployment?, 3 Favorite Stocks

Congress Drags Its Feet as Markets Fall, 30% Unemployment?, 3 Favorite Stocks

St. Louis Fed Pres. James Bullard sees unemployment possibly hitting 30%, while GDP could ultimately contract 50%.

Here's My Watchlist of 12 Covid-19 Stock Plays

Here's My Watchlist of 12 Covid-19 Stock Plays

If this group begins to outperform, then I'd use it as an indication of caution.

These Are the Times We Live In

These Are the Times We Live In

Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.

The Magic Mice of Regeneron

The Magic Mice of Regeneron

I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.

Thank the Fed, Cessation of Economic Activity, Rescuing Airlines, 3 Key Stocks

Thank the Fed, Cessation of Economic Activity, Rescuing Airlines, 3 Key Stocks

When the central bank is on top of their game as they have been of late, credit must go where credit is due.

5 Leading Biotechs in Search of a Coronavirus Vaccine

5 Leading Biotechs in Search of a Coronavirus Vaccine

The race is on. The prize could be countless lives saved and perhaps billions of dollars in revenue.

Real Money Post Industrial Average Holds Own Amid Covid-19 Selloff

Real Money Post Industrial Average Holds Own Amid Covid-19 Selloff

Amid a flood of corporate warnings over the coronavirus, all the major stock market indexes finished last month down 6.4% to 10.1%.

Roller Coaster Markets, Time for Emergency Measures, 3 Stock Groups to Focus On

Roller Coaster Markets, Time for Emergency Measures, 3 Stock Groups to Focus On

I'll stick to the three-pronged approach... the Rebound group, the Virus group, and the Revenue group.

Jim Cramer: I Don't Know Where It Will Bottom, I Do Know What to Buy and Sell

Jim Cramer: I Don't Know Where It Will Bottom, I Do Know What to Buy and Sell

This is the time to high grade your portfolio, take some losses and move to better stocks.

Jim Cramer: Here Are 10 Stocks for a Stay-at-Home Pandemic

Jim Cramer: Here Are 10 Stocks for a Stay-at-Home Pandemic

These companies should continue to work, while we wait for a cure or a vaccine or the darned virus to run its course.

Playing the Hand You're Dealt

Playing the Hand You're Dealt

Check out just a few of the year-to-date moves coming into Thursday on 8 companies you've never heard of before the last week or two.

Moderna Could Spike Much Higher as the Pandemic Story Plays Out

Moderna Could Spike Much Higher as the Pandemic Story Plays Out

Hot money will be attracted to stocks that show promise in dealing with the coronavirus.

Jim Cramer: 3 Market Storylines Are In Play, But Which Is Best for Investors?

Jim Cramer: 3 Market Storylines Are In Play, But Which Is Best for Investors?

Only one of these scenarios is going to get you in and out of this market with your assets intact and your portfolio stronger.

Jim Cramer: Hope for the Best, Plan for the Worst

Jim Cramer: Hope for the Best, Plan for the Worst

Is this the end of the world? No. You still need to plan for your financial well-being, even as the CDC tells us 'this might be bad.'

Jim Cramer: Want the Bulls' Biggest Nightmare? Here It Is

Jim Cramer: Want the Bulls' Biggest Nightmare? Here It Is

This entirely logical scenario would pull the rug out from under the bull market.

Moderna Could Rally Further Amid Coronavirus Concerns

Moderna Could Rally Further Amid Coronavirus Concerns

Massachusetts biotech works on drug development based on messenger RNA.

Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

These companies all could be strong -- even if the 2019 nCoV fear spreads.

Moderna's Small Base Could Surprise on the Upside

Moderna's Small Base Could Surprise on the Upside

Prices have moved above the early January high giving us the simple definition of an uptrend.

Fear of Missing Out Is the Main Driving Force in This Market

Fear of Missing Out Is the Main Driving Force in This Market

Stick to your methodology and don't let worry of underperformance push you to shift your approach.